BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9631817)

  • 1. Heart or lung disease: determining the primary cause for dyspnea on exertion.
    Mohnssen SR; Weisman IM; Zeballos RJ; Hall A; Wasserman K; Tavel ME
    Chest; 1998 Jun; 113(6):1705-10. PubMed ID: 9631817
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamics in the cardiac catheterization laboratory of the 21st century.
    Nishimura RA; Carabello BA
    Circulation; 2012 May; 125(17):2138-50. PubMed ID: 22547754
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of pulmonary hypertension during exercise: ready for clinical prime time?
    Maréchaux S; Ennezat PV
    Arch Cardiovasc Dis; 2011 Apr; 104(4):211-5. PubMed ID: 21624787
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of Lomir (isradipine) on the tolerance for physical loading and on the gas exchange indices of patients with primary pulmonary hypertension].
    Chazova IE; Belenkov IuN; Mareev VIu; Floria VG; Sinitsyn VE; Nakonechnikov SN
    Ter Arkh; 1994; 66(9):54-7. PubMed ID: 7992215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary Exercise Testing in Pulmonary Hypertension.
    Weatherald J; Farina S; Bruno N; Laveneziana P
    Ann Am Thorac Soc; 2017 Jul; 14(Supplement_1):S84-S92. PubMed ID: 28375670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center.
    Huang W; Resch S; Oliveira RK; Cockrill BA; Systrom DM; Waxman AB
    Eur J Prev Cardiol; 2017 Jul; 24(11):1190-1199. PubMed ID: 28506086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary pulmonary hypertension].
    Paleev NR; Tsar'kova LN; Shanin NI; Chereĭskaia NK; Kriuchkova GS
    Sov Med; 1987; (12):6-12. PubMed ID: 2965417
    [No Abstract]   [Full Text] [Related]  

  • 8. Exercise Intolerance in Heart Failure: Central Role for the Pulmonary System.
    Lalande S; Cross TJ; Keller-Ross ML; Morris NR; Johnson BD; Taylor BJ
    Exerc Sport Sci Rev; 2020 Jan; 48(1):11-19. PubMed ID: 31453845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic precapillary pulmonary hypertension (primary and thromboembolic): a frequently misdiagnosed cause of dyspnea].
    Allgöwer E; Wyss P; Poli S
    Rev Med Suisse Romande; 1988 May; 108(5):383-94. PubMed ID: 3399771
    [No Abstract]   [Full Text] [Related]  

  • 11. Exercise intolerance in pulmonary arterial hypertension. The role of cardiopulmonary exercise testing.
    Neder JA; Ramos RP; Ota-Arakaki JS; Hirai DM; D'Arsigny CL; O'Donnell D
    Ann Am Thorac Soc; 2015 Apr; 12(4):604-12. PubMed ID: 25897744
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary pulmonary hypertension.
    Ashinsky D
    Postgrad Med; 1991 Aug; 90(2):249-50, 253. PubMed ID: 1862047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis.
    Gläser S; Noga O; Koch B; Opitz CF; Schmidt B; Temmesfeld B; Dörr M; Ewert R; Schäper C
    Respir Med; 2009 Feb; 103(2):317-24. PubMed ID: 18804360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea?
    Milani RV; Lavie CJ; Mehra MR
    Circulation; 2004 Jul; 110(4):e27-31. PubMed ID: 15277333
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe dyspnoea on light exercise at high altitude: unusual presentation of Ebstein's anomaly.
    Dencker M; Stagmo M; Wollmer P
    Int J Cardiol; 2008 Mar; 125(1):e14-5. PubMed ID: 17368588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts?
    Pamidi S; Mehta S
    J Rheumatol; 2009 Feb; 36(2):216-8. PubMed ID: 19208554
    [No Abstract]   [Full Text] [Related]  

  • 17. [Objective evidence of exercise intolerance. Differential diagnosis of cardiac and pulmonary dyspnea].
    Corrà U; Bosimini E
    Ital Heart J Suppl; 2000 Mar; 1(3):379-83. PubMed ID: 10815267
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of overestimation or underestimation of the functional capacity using MRC score as compared to 6-minute walk test in patients with cardio-respiratory disorders.
    Callens E; Graba S; Essalhi M; Gillet-Juvin K; Chevalier-Bidaud B; Chenu R; Mahut B; Delclaux C
    COPD; 2014 Sep; 11(5):496-502. PubMed ID: 24832477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of breathlessness in the detection of pulmonary hypertension.
    Blasi F
    Eur Respir Rev; 2012 Mar; 21(123):1-3. PubMed ID: 22379166
    [No Abstract]   [Full Text] [Related]  

  • 20. The invasive cardiopulmonary exercise test.
    Maron BA; Cockrill BA; Waxman AB; Systrom DM
    Circulation; 2013 Mar; 127(10):1157-64. PubMed ID: 23479667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.